OTCMKTS:OPRX - OptimizeRx Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$13.95 -0.05 (-0.36 %)
(As of 11/16/2018 04:00 PM ET)
Previous Close$13.95
Today's Range$13.76 - $15.2399
52-Week Range$2.30 - $18.39
Volume20,687 shs
Average Volume44,701 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
OptimizeRx Corporation provides digital health messaging to the pharmaceutical industry. The company offers a direct channel for pharmaceutical companies to communicate with healthcare providers. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies; and brand messaging services, such as various brand awareness and clinical messaging services consisting of brand awareness messages, reminder ads, clinical messages, and unbranded messages that could be targeted by specialty, diagnostic code, and other criteria. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. OptimizeRx Corporation is based in Rochester, Michigan.

Receive OPRX News and Ratings via Email

Sign-up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolOTCMKTS:OPRX
Previous Symbol
CUSIPN/A
Phone248-651-6568

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees24
Outstanding Shares12,010,000
Market Cap$0.00
OptionableNot Optionable

OptimizeRx (OTCMKTS:OPRX) Frequently Asked Questions

What is OptimizeRx's stock symbol?

OptimizeRx trades on the OTCMKTS under the ticker symbol "OPRX."

How were OptimizeRx's earnings last quarter?

OptimizeRx Co. (OTCMKTS:OPRX) released its quarterly earnings results on Monday, November, 5th. The technology company reported $0.02 EPS for the quarter, topping the consensus estimate of $0.01 by $0.01. The technology company had revenue of $5.42 million for the quarter, compared to the consensus estimate of $5.28 million. View OptimizeRx's Earnings History.

What price target have analysts set for OPRX?

3 equities research analysts have issued 1 year target prices for OptimizeRx's stock. Their predictions range from $17.00 to $18.00. On average, they expect OptimizeRx's stock price to reach $17.50 in the next year. This suggests a possible upside of 25.4% from the stock's current price. View Analyst Price Targets for OptimizeRx.

What is the consensus analysts' recommendation for OptimizeRx?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OptimizeRx in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for OptimizeRx.

Has OptimizeRx been receiving favorable news coverage?

Press coverage about OPRX stock has trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. OptimizeRx earned a coverage optimism score of 1.2 on InfoTrie's scale. They also gave news stories about the technology company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Who are some of OptimizeRx's key competitors?

Who are OptimizeRx's key executives?

OptimizeRx's management team includes the folowing people:
  • Mr. William J. Febbo, CEO & Director (Age 49)
  • Ms. Miriam J. Paramore, Pres (Age 55)
  • Mr. Douglas P. Baker, Chief Financial Officer (Age 61)
  • Mr. Terence J. Hamilton, Sr. VP of Sales (Age 53)
  • Mr. Ed Berger, Sr. VP of Marketing

Who are OptimizeRx's major shareholders?

OptimizeRx's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Russell Investments Group Ltd. (0.73%), Wasatch Advisors Inc. (0.59%), Intellectus Partners LLC (0.54%), EAM Investors LLC (0.45%) and Family Management Corp (0.11%). Company insiders that own OptimizeRx stock include Douglas P Baker, Ellen O'connor Vos, Gus D Halas, Miriam J Paramore, Patrick D Spangler and William J Febbo. View Institutional Ownership Trends for OptimizeRx.

Which major investors are selling OptimizeRx stock?

OPRX stock was sold by a variety of institutional investors in the last quarter, including Family Management Corp. View Insider Buying and Selling for OptimizeRx.

Which major investors are buying OptimizeRx stock?

OPRX stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Wasatch Advisors Inc., Intellectus Partners LLC and EAM Investors LLC. Company insiders that have bought OptimizeRx stock in the last two years include Douglas P Baker, Ellen O'connor Vos, Gus D Halas, Miriam J Paramore, Patrick D Spangler and William J Febbo. View Insider Buying and Selling for OptimizeRx.

How do I buy shares of OptimizeRx?

Shares of OPRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OptimizeRx's stock price today?

One share of OPRX stock can currently be purchased for approximately $13.95.

What is OptimizeRx's official website?

The official website for OptimizeRx is http://www.optimizerx.com.

How can I contact OptimizeRx?

OptimizeRx's mailing address is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. The technology company can be reached via phone at 248-651-6568 or via email at [email protected]


MarketBeat Community Rating for OptimizeRx (OTCMKTS OPRX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  87 (Vote Outperform)
Underperform Votes:  107 (Vote Underperform)
Total Votes:  194
MarketBeat's community ratings are surveys of what our community members think about OptimizeRx and other stocks. Vote "Outperform" if you believe OPRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OPRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel